{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "transcribes",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P37840",
      "entity_text" : "SNCA",
      "entity_type" : "gene"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0990" ],
      "Organ" : [ "uberon:UBERON:0000105" ],
      "CellType" : [ "cl:CL:0000540" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "For example, an eQTL affecting Parkinson disease risk through expression of SNCA was recently shown to act through the disruption of an enhancer; XREF_BIBR if this enhancer is specific to a disease-relevant cell type, such as nerve cells of the substantia nigra, then it could manifest as a conditional eQTL since it would be only partially represented in brain homogenate.",
  "reading_complete" : "2020-08-08T14:33:01Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T14:29:14Z",
  "trigger" : "expression",
  "evidence" : [ "expression of SNCA" ],
  "pmc_id" : "5993513",
  "score" : 0
}